This was recently illustrated by Loureiro et al. [24], who demonstrated that intraperitoneal administration of TGF-β1-blocking peptides to mice exposed to PD fluid significantly decreased peritoneal fibrosis and angiogenesis and improved peritoneal ultrafiltration. Here, TGFB1 is linked to Peritoneal Fibrosis.